Zobrazeno 1 - 10
of 104
pro vyhledávání: '"Hanmant, Barkate"'
Autor:
Tarini Prasad Sahoo, Chirag Desai, Shyam Agarwal, Amit Rauthan, Boman Dhabhar, Ghanshyam Biswas, Sandeep Batra, Rajat Saha, Arun Philip, Vijay Agarwal, Palanki Satya Dattatreya, PN Mohapatra, Chetan Deshmukh, Sagar Bhagat, Saiprasad Patil, Hanmant Barkate
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-13 (2023)
Abstract In advanced Renal Cell Carcinoma (aRCC), systemic therapy is the mainstay of treatment, with no or little role for surgery in these patients. Tyrosine kinase inhibitors (TKIs) and immune-oncological (IOs) therapies, either alone or in combin
Externí odkaz:
https://doaj.org/article/63bb52e8c3304decb700ec7898d8f205
Autor:
Manjunath Shenoy, Shital Poojari, Madhu Rengasamy, Maya Vedmurthy, Shyamanta Barua, Dhiraj Dhoot, Hanmant Barkate
Publikováno v:
Indian Dermatology Online Journal, Vol 14, Iss 3, Pp 347-356 (2023)
Background: In spite of the availability of multiple consensus statements on dermatophytosis management, different treatment approaches have been experienced in India and require more scrutiny to further update guidelines and improve patient care. Ai
Externí odkaz:
https://doaj.org/article/eee0c2b18e8749969b679e962675fbde
Publikováno v:
Antibiotics, Vol 12, Iss 9, p 1455 (2023)
Acne vulgaris is characterized by inflammatory and non-inflammatory skin lesions with a high prevalence among adolescents in India. Not enough studies are reported on the use of topical antibiotics for the management of acne in the Indian population.
Externí odkaz:
https://doaj.org/article/f4af4b7f43c04ffabed9b87d999aadf7
Autor:
Sundeep Salvi, Manish K Jain, Srikanth Krishnamurthy, Akash Balki, Rahul Kodgule, Monika Tandon, Sagar Bhagat, Sagar Panchal, Nishtha Khatri, Wen Wu, Amol Pendse, Saiprasad Patil, Hanmant Barkate
Publikováno v:
Lung India, Vol 39, Iss 6, Pp 517-524 (2022)
Background: The safety and efficacy of fixed-dose combination (FDC) of glycopyrronium bromide 12.5 μg/formoterol fumarate 12 μg (GB/FF) twice daily as dry powder inhalers (DPIs) compared to glycopyrronium 50 μg monotherapy (GLY) once daily as DPI
Externí odkaz:
https://doaj.org/article/052dbb819fae4f47a2236abea3e17974
Autor:
Manoj Chadha, Subodh Banzal, S. Sridhar, Soumik Goswam, Hanmant Barkate, Sachin Suryawanshi, Mayur Jadhav, Manasi Brid
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 16, Iss 01, Pp 16-19 (2022)
Introduction: Diabetes Mellitus (DM) has become the leading health concern worldwide over the last few decades. But despite advances in both understanding of the pathophysiology of Type 2 Diabetes Mellitus (T2DM), and the development of new treat
Externí odkaz:
https://doaj.org/article/8e0e3947f8cb43e7b6e711ed228e2889
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-5 (2021)
Abstract Background Chemotherapy induced nausea- vomiting (CINV) is considered as the most common, feared and most troublesome side effect of chemotherapy. NEPA (NEtupitant 300 mg + PAlonosetron 0.50 mg) is the first commercially available oral fixed
Externí odkaz:
https://doaj.org/article/bd27045ca3a24b8dbb05554950d05d0c
Autor:
Zarir F. Udwadia, Pawan Singh, Hanmant Barkate, Saiprasad Patil, Shabbir Rangwala, Amol Pendse, Jatin Kadam, Wen Wu, Cynthia F. Caracta, Monika Tandon
Publikováno v:
International Journal of Infectious Diseases, Vol 103, Iss , Pp 62-71 (2021)
Objective: To assess the efficacy and safety of favipiravir in adults with mild-to-moderate coronavirus disease 2019 (COVID-19). Methods: In this randomized, open-label, parallel-arm, multicenter, phase 3 trial, adults (18–75 years) with RT-PCR con
Externí odkaz:
https://doaj.org/article/4e4066fdaf884deba2ec80352ad2f675
Autor:
Shashank Joshi, Jalil Parkar, Abdul Ansari, Agam Vora, Deepak Talwar, Mangesh Tiwaskar, Saiprasad Patil, Hanmant Barkate
Publikováno v:
International Journal of Infectious Diseases, Vol 102, Iss , Pp 501-508 (2021)
The coronavirus disease-2019 (COVID-19) outbreak all over the world has led the researchers to strive to develop drugs or vaccines to prevent or halt the progression of this ailment. To hasten the treatment process, repurposed drugs are being evaluat
Externí odkaz:
https://doaj.org/article/2958a3f74f5443658cc11941a5674986
Publikováno v:
Clinical Dermatology Review, Vol 5, Iss 2, Pp 183-186 (2021)
Background: Apremilast is recommended to titrate in initial period to reduce adverse effects (AE). But inspite of that, in India; many dermatologists experienced a lot of AE resulting in discontinuation of therapy. As a result, many of them have adap
Externí odkaz:
https://doaj.org/article/47aaf8acc4b8417db1e2f11941f38c10
Autor:
Raja Dhar, Deepak Talwar, Sundeep Salvi, B.V. Muralimohan, Sagar Panchal, Saiprasad Patil, Sagar Bhagat, Nishtha Khatri, Hanmant Barkate
Publikováno v:
ERJ Open Research, Vol 8, Iss 1 (2022)
Obstructive airway disease (OAD), which includes COPD and asthma, is the leading cause of morbidity and mortality in India. Long-acting bronchodilators (long-acting β2 agonists (LABAs) and/or long-acting muscarinic antagonists (LAMAs)) and inhaled c
Externí odkaz:
https://doaj.org/article/2c05dc35cac54099bda7707b4e0e17fa